YU3696A - Poboljšana sinteza ciklopropilacetilena - Google Patents

Poboljšana sinteza ciklopropilacetilena

Info

Publication number
YU3696A
YU3696A YU3696A YU3696A YU3696A YU 3696 A YU3696 A YU 3696A YU 3696 A YU3696 A YU 3696A YU 3696 A YU3696 A YU 3696A YU 3696 A YU3696 A YU 3696A
Authority
YU
Yugoslavia
Prior art keywords
synthesis
improved
cyclopropylacethylene
cyclopropylacetylene
reverse transcriptase
Prior art date
Application number
YU3696A
Other languages
English (en)
Inventor
Andrew Tompson
Edward Corley
Martha Huntington
Original Assignee
Merck & Co. Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co. Inc. filed Critical Merck & Co. Inc.
Publication of YU3696A publication Critical patent/YU3696A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C13/00—Cyclic hydrocarbons containing rings other than, or in addition to, six-membered aromatic rings
    • C07C13/02—Monocyclic hydrocarbons or acyclic hydrocarbon derivatives thereof
    • C07C13/04—Monocyclic hydrocarbons or acyclic hydrocarbon derivatives thereof with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C1/00—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon
    • C07C1/26—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon starting from organic compounds containing only halogen atoms as hetero-atoms
    • C07C1/30—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon starting from organic compounds containing only halogen atoms as hetero-atoms by splitting-off the elements of hydrogen halide from a single molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Opisana je poboljšana sinteza ciklopropilacetilena, intermedijara za veoma jak inhibitor HIV reverzne transkriptaze.
YU3696A 1995-01-23 1996-01-22 Poboljšana sinteza ciklopropilacetilena YU3696A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/376,611 US5663467A (en) 1995-01-23 1995-01-23 Synthesis of cyclopropylacetylene

Publications (1)

Publication Number Publication Date
YU3696A true YU3696A (sh) 1998-11-05

Family

ID=23485719

Family Applications (1)

Application Number Title Priority Date Filing Date
YU3696A YU3696A (sh) 1995-01-23 1996-01-22 Poboljšana sinteza ciklopropilacetilena

Country Status (23)

Country Link
US (1) US5663467A (sh)
EP (1) EP0805790B1 (sh)
JP (1) JP3107829B2 (sh)
KR (1) KR19980701577A (sh)
CN (1) CN1056824C (sh)
AR (1) AR000771A1 (sh)
AT (1) ATE186903T1 (sh)
AU (1) AU692674B2 (sh)
BR (1) BR9606782A (sh)
CA (1) CA2210577A1 (sh)
CZ (1) CZ234997A3 (sh)
DE (1) DE69605282T2 (sh)
DK (1) DK0805790T3 (sh)
EA (1) EA000074B1 (sh)
ES (1) ES2140062T3 (sh)
FI (1) FI973086L (sh)
GR (1) GR3032200T3 (sh)
HR (1) HRP960029B1 (sh)
HU (1) HUP9800849A3 (sh)
NZ (1) NZ301206A (sh)
SK (1) SK99997A3 (sh)
WO (1) WO1996022955A1 (sh)
YU (1) YU3696A (sh)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3736197A (en) * 1996-07-26 1998-02-20 Du Pont Pharmaceuticals Company A practical synthesis of benzoxazinones useful as hiv reverse transcripta se inhibitors
ZA9711256B (en) 1996-12-16 1999-06-15 Du Pont Merck Pharma Asymmetric synthesis of benzoxazinones
US5932726A (en) * 1996-12-16 1999-08-03 Dupont Pharmaceuticals Company Asymmetric synthesis of benzoxazinones
US6028237A (en) * 1996-12-16 2000-02-22 Dupont Pharmaceuticals Company Synthesis of cyclopropylacetylene
US5955627A (en) * 1996-12-16 1999-09-21 Kuraray Co., Ltd. Process for the preparation of cyclopropylacetylene derivatives
US5965729A (en) 1997-02-05 1999-10-12 Merck & Co., Inc. Process for the crystallization of a reverse transcriptase inhibitor using an anti-solvent
CZ304186B6 (cs) * 1997-02-05 2013-12-11 Merck Sharp & Dohme Corp. Krystalická forma I inhibitoru na bázi benzoxazinu a zpusob její výroby
US6207864B1 (en) 1997-03-07 2001-03-27 Basf Aktiengesellschaft Process for preparing cyclopropylacetylene
JP2001519810A (ja) * 1997-04-07 2001-10-23 デュポン ファーマシューティカルズ カンパニー 新規中間体を経由するベンゾオキサジノン類の不斉合成
AR011731A1 (es) * 1997-05-16 2000-08-30 Merck & Co Inc Un proceso de reaccion de adicion enantioselectiva eficiente utilizando un reactivo de organozinc.
CN1265087A (zh) * 1997-07-31 2000-08-30 杜邦药品公司 环丙基乙炔的制备方法
CA2298835A1 (en) * 1997-08-06 1999-02-18 Merck & Co., Inc. Efficient synthesis of cyclopropylacetylene
US6072094A (en) * 1997-08-06 2000-06-06 Merck & Co., Inc. Efficient synthesis of cyclopropylacetylene
EP0922686B1 (de) * 1997-12-10 2002-02-06 Lonza A.G. Verfahren zur Herstellung von Ethinylcyclopropan
KR100350752B1 (ko) * 1998-02-06 2002-08-28 가부시키가이샤 구라레 시클로프로필아세틸렌 유도체의 제조방법
US5952537A (en) 1998-03-13 1999-09-14 Wiley Organics, Inc. Preparation of cycloalkylacetylene compounds using dialkylaminomagnesium halide or bis(dialkylamino)magnesium
UA72207C2 (uk) * 1998-04-07 2005-02-15 Брістол- Майєрс Сквібб Фарма Компані Фармацевтична композиція ефавіренцу з добавкою дезінтегруючих агентів у вигляді швидкорозчинних капсул або таблеток та спосіб її виготовлення
US20010014352A1 (en) 1998-05-27 2001-08-16 Udit Batra Compressed tablet formulation
US6235957B1 (en) 1998-06-29 2001-05-22 Dupont Pharmaceuticals Company Process for the preparation of cyclopropylacetylene
US6359164B1 (en) 1998-10-01 2002-03-19 Zhe Wang Process for the preparation of cyclopropylacetylene
US6288297B1 (en) 1998-10-01 2001-09-11 Dupont Pharmaceuticals Company Process for the preparation of cyclopropylacetylene
GB2355988A (en) 1999-10-28 2001-05-09 Merck & Co Inc Synthesis of cyclopropylacetylene in a one-pot process using a diazo-keto-phos phonate
GB2355724A (en) * 1999-10-28 2001-05-02 Merck & Co Inc Synthesis of cyclopropylacetylene from propiolic acid (2-propynoic acid)
US8080655B2 (en) * 2009-07-20 2011-12-20 Apotex Pharmachem Inc. Methods of making efavirenz and intermediates thereof
EP2471783A1 (en) 2010-12-23 2012-07-04 Esteve Química, S.A. Novel polymorphic form of efavirenz
CN103254087B (zh) * 2013-06-07 2015-03-18 郑州大学 依非韦伦中间体的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU578293A1 (ru) * 1972-02-04 1977-10-30 Институт Органической Химии Имени Н.Д.Зелинского Ан Ссср Способ получени циклопропилацетилена
SU555079A1 (ru) * 1976-01-30 1977-04-25 Институт органической химии им.Н.Д.Зелинского АН СССР Способ получени циклопропилацетилена
SU572445A1 (ru) * 1976-04-05 1977-09-15 Институт Органической Химии Имени Н.Д. Зелинского Ан Ссср Способ получени циклопропилацетилена

Also Published As

Publication number Publication date
HRP960029A2 (en) 1997-08-31
DE69605282D1 (en) 1999-12-30
JP3107829B2 (ja) 2000-11-13
CZ234997A3 (cs) 1998-02-18
FI973086A0 (fi) 1997-07-22
DE69605282T2 (de) 2000-07-13
AU4657496A (en) 1996-08-14
EA199700139A1 (ru) 1997-12-30
CN1056824C (zh) 2000-09-27
FI973086A7 (fi) 1997-07-22
EP0805790A1 (en) 1997-11-12
AR000771A1 (es) 1997-08-06
SK99997A3 (en) 1998-05-06
HUP9800849A3 (en) 2001-01-29
DK0805790T3 (da) 2000-05-01
CA2210577A1 (en) 1996-08-01
BR9606782A (pt) 1997-12-30
MX9705562A (es) 1997-10-31
ES2140062T3 (es) 2000-02-16
JPH10512880A (ja) 1998-12-08
ATE186903T1 (de) 1999-12-15
NZ301206A (en) 1998-11-25
HRP960029B1 (en) 2000-12-31
EP0805790B1 (en) 1999-11-24
KR19980701577A (ko) 1998-05-15
FI973086L (fi) 1997-07-22
EA000074B1 (ru) 1998-06-25
US5663467A (en) 1997-09-02
GR3032200T3 (en) 2000-04-27
CN1169137A (zh) 1997-12-31
WO1996022955A1 (en) 1996-08-01
HUP9800849A2 (hu) 1999-01-28
AU692674B2 (en) 1998-06-11

Similar Documents

Publication Publication Date Title
YU3696A (sh) Poboljšana sinteza ciklopropilacetilena
ES2173341T3 (es) Compuestos inhibidores de proteasa retroviral.
LV12430A (lv) Slapekli saturosi heteroaromatiski savienojumi ka xa faktora inhibitori
DK1007092T3 (da) En fremgangsmåde til inhibering af komplementaktivering via det alternative forlöb
DK0656887T3 (da) Hydroxyethylaminosulfonamider til anvendelse som inhibitorer af retrovirale proteaser
DK0960109T3 (da) Fremgangsmåde til fremstilling af tolterodin
DK1040108T3 (da) Orthoanthranilamidderivater som antikoagulanter
NO950550L (no) Sulfonylalkanoylamino-hydroksyetylaminosulfonamider som er nyttige som retrovirale proteaseinhibitorer
ES2164842T3 (es) Procedimiento para la preparacion de composiciones de microcapsulas.
AR038427A2 (es) Compuestos 15-alquil-14-hidroxilo de marcfortina y parahercuamida
ES2123303T3 (es) Procedimiento para la fabricacion de cuerpos sinterizados de alfa-al2o3, asi como el uso de los mismos.
TR199701146T1 (xx) N�rotensin resept�rleri �zerinde etkili 1-Fenilpirazol-3-Karboksamidler.
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
DK0859766T3 (da) Chirale methylphenyloxazolidinoner
DE69808619D1 (de) Prostaglandin-pharmazeutische-zusammensetzungen
DK0687260T3 (da) Fremgangsmåde til fremstillingen af 9-desoxotaxaner
AR004375A1 (es) Acero para la fabricacion de piezas de mecanica cortables y pieza obtenida
ES2184304T3 (es) Procedimiento de preparacion de un perhidro-isoindol sustituido.
AU4765396A (en) Method of preparing retroviral protease inhibitor intermediates
MX9706744A (es) Proceso novedosos para preparar derivados de 2,3-dihidro-benzofuranol.
DK0891186T3 (da) Nasal administration af middel til behandling af forsinket opkastning
UY24596A1 (es) Nuevos derivados sintéticos del catecol
DK1307436T3 (da) Fremgangsmåde til fremstilling af baccatin III-derivater
ES2157419T3 (es) Arilazadioxacicloalquenos substituidos, fungicidas.
DK1255759T3 (da) Synteseproces for et mellemprodukt for ectainascidin- og phthalascidin-forbindelser